| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/24/2002 | WO2002005627A1 Ctr1 homologue from melon |
| 01/24/2002 | WO2001082780A3 Method for treating cancer, visualizing cell structures, and isolating organelles using organelle crystallizing agents |
| 01/24/2002 | WO2001079526A3 Live cell procedures to identify compounds modulating intracellular distribution of phosphodiesterase (pde) enzymes |
| 01/24/2002 | WO2001079440A3 Extracellular expression of pectate lyase using bacillus or escherichia coli |
| 01/24/2002 | WO2001075111A3 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 01/24/2002 | WO2001075012A3 A novel polypeptide, human signal peptide 10 of a lipoprotein precursor protein and the polynucleotide encoding the polypeptide |
| 01/24/2002 | WO2001074130A3 A computer based method for identifying conserved invariant peptide motifs |
| 01/24/2002 | WO2001072998A3 Method for extracting nucleic acids |
| 01/24/2002 | WO2001070767A3 Therapeutic anti-melanoma compounds |
| 01/24/2002 | WO2001068869A3 Human g-coupled protein receptor kinsaes and polynucleotides encoding the same |
| 01/24/2002 | WO2001068844A3 Regulation of human leukotriene b4-like g protein-coupled receptor |
| 01/24/2002 | WO2001068842A3 Regulation of human p2y-like gpcr protein |
| 01/24/2002 | WO2001064900A3 Aspartate carbamyltransferase as herbicidal target |
| 01/24/2002 | WO2001064750A3 Modulation of the activity of the endothelial cel surface receptor ecrtp/dep-1 in the regulation of angiogenesis |
| 01/24/2002 | WO2001062781A3 Homogentisate phytyl transferase |
| 01/24/2002 | WO2001060838A3 Aids ancestral viruses and vaccines |
| 01/24/2002 | WO2001060794A3 Method for screening for anti-amyloidogenic properties and method for treatment of neurodegenerative disease |
| 01/24/2002 | WO2001059115A3 83p5g4: a tissue specific protein highly expressed in prostate cancer |
| 01/24/2002 | WO2001059073A3 Cytotoxic t lymphocytes activated by dendritic cell hybrids |
| 01/24/2002 | WO2001055324A3 Nucleic acids, proteins, and antibodies |
| 01/24/2002 | WO2001055305A3 Nucleic acids, proteins, and antibodies |
| 01/24/2002 | WO2001053324A3 Novel haptotactic peptides |
| 01/24/2002 | WO2001052892A3 Jak/stat pathway inhibitors and the uses thereof |
| 01/24/2002 | WO2001051621A3 Dna polymerase mutant having one or more mutations in the active site |
| 01/24/2002 | WO2001051515A3 Genes differentially expressed in breast cancer |
| 01/24/2002 | WO2001046258A3 Transporters and ion channels |
| 01/24/2002 | WO2001044459A3 Method to enhance agrobacterium-mediated transformation of plants |
| 01/24/2002 | WO2001044286A3 Five-helix protein |
| 01/24/2002 | WO2001044285A3 Development of resistance to raspberry bushy dwarf virus |
| 01/24/2002 | WO2001042505A3 Fluorescent quenching detection reagents and methods |
| 01/24/2002 | WO2001042465A3 Chordin-like molecules and uses thereof |
| 01/24/2002 | WO2001042293A3 Rad3 ORTHOLOGUE-1 AND USES THEREOF |
| 01/24/2002 | WO2001041785A3 Enzyme treatment for infection |
| 01/24/2002 | WO2001039797A3 Artificial chromosome constructs containing nucleic acid sequences capable of directing the formation of a recombinant rna-virus |
| 01/24/2002 | WO2001038504A3 Homologous recombination in plants |
| 01/24/2002 | WO2001036977A8 Identification of disease markers involving mass-based-separation |
| 01/24/2002 | WO2001036595A3 Methods for conditional transgene expression and trait removal in plants |
| 01/24/2002 | WO2001036470A3 Methods and compositions for detection and treatment of breast cancer, based on breast cancer-associated polypeptides |
| 01/24/2002 | WO2001036005A3 Targeted delivery of therapeutic and diagnostic moieties |
| 01/24/2002 | WO2001034795A3 Casb7435 polypeptide, nucleic acid encoding it, and their uses in treatment and diagnosis |
| 01/24/2002 | WO2001034768A3 15 human secreted proteins |
| 01/24/2002 | WO2001032910A3 27 human secreted proteins |
| 01/24/2002 | WO2001032711B1 Adeno-associated virus aav rep78 major regulatory protein, mutants thereof and uses thereof |
| 01/24/2002 | WO2001031049A3 Production of polyketides |
| 01/24/2002 | WO2001029221A3 Proteins and polynucleotides encoding them |
| 01/24/2002 | WO2001029211A3 Method for directed evolution by random chimeragenesis on transient templates |
| 01/24/2002 | WO2001027276A3 Dna sequences from breast tumor and uses thereof |
| 01/24/2002 | WO2001025488A3 Method for enrichment of natural antisense messenger rna |
| 01/24/2002 | WO2001025483A3 Compositions for dna amplification, synthesis, and mutagenesis |
| 01/24/2002 | WO2001025436A3 Endozepine-like polypeptides and polynucleotides encoding same |
| 01/24/2002 | WO2001025397A3 Compositions and methods for tumor-targeted delivery of effector molecules |
| 01/24/2002 | WO2001023562A3 Osteoprotegerin regulatory region |
| 01/24/2002 | WO2001023409A8 38 human secreted proteins |
| 01/24/2002 | WO2001022810A3 Transgenic animals expressing von willebrand factor (vwf) and vwf-related polypeptides |
| 01/24/2002 | WO2001019860A3 Proteins associated with cell differentiation |
| 01/24/2002 | WO2001019855A3 Pharmaceutical compositions and methods of using secreted frizzled related protein |
| 01/24/2002 | WO2001016290A3 Dna encoding the human serine protease eos |
| 01/24/2002 | WO2001015511A3 Identification of peptides that facilitate uptake and cytoplasmic and/or nuclear transport of proteins, dna and viruses |
| 01/24/2002 | WO2001014417A3 Pesticidal proteins |
| 01/24/2002 | WO2001012856A3 Analysis of sequence tags with hairpin primers |
| 01/24/2002 | WO2001012819A3 Protein phosphatases and diagnosis and treatment of phosphatase-related disorders |
| 01/24/2002 | WO2001008708A3 Enhanced delivery via serpin enzyme complex receptor ligands |
| 01/24/2002 | WO2000073478A9 Recombinant adenoviral vectors expressing chimeric fiber proteins for cell specific infection and genome integration |
| 01/24/2002 | WO2000073453A9 T-bet compositions and methods of use thereof |
| 01/24/2002 | WO2000073338A9 Compositions and methods for the therapy, diagnosis and monitoring of breast cancer |
| 01/24/2002 | WO2000071574A3 Antigenic neisserial peptides |
| 01/24/2002 | US20020010952 Nucleotide sequences coding plant protein; for use in hop culturing |
| 01/24/2002 | US20020010950 Nucleotide sequences coding preferential polypeptide; for use as tool in genetic engineering |
| 01/24/2002 | US20020010949 Cloning using donor nuclei from differentiated fetal and adult cells |
| 01/24/2002 | US20020010947 Transgenic mouse model of human neurodegenerative disease |
| 01/24/2002 | US20020010328 Genetic engineering |
| 01/24/2002 | US20020010325 Complexing; purified polypeptide |
| 01/24/2002 | US20020010324 Genetic engineering; polypeptides |
| 01/24/2002 | US20020010323 Isolation method and apparatus |
| 01/24/2002 | US20020010318 Enzyme inhibitor; for use in treatment of lung defects, asthma, bronchitis, emphysema and respiratory system disorders |
| 01/24/2002 | US20020010145 Apparatus, methods and compositions for biotechnical separations |
| 01/24/2002 | US20020010136 Having an increased positive regulatory activity for expression of tyrosine phenol lyase gene, a gene coding for the same; biosynthesis of L-3,5-dihydroxyphenylalanine (L-DOPA) |
| 01/24/2002 | US20020009804 32705, 23224, 27423, 32700, 32712, novel human G-proteins |
| 01/24/2002 | US20020009801 Nucleotide sequences coding enzymatic polypeptide for use in biological pest control; herbicides |
| 01/24/2002 | US20020009800 Genetically engineeered sequences for use in gene therapy of central nervous system |
| 01/24/2002 | US20020009799 Contacting a cell with a solution of a biopolymer-degrading enzyme, but not a nuclease, and contacting the cell with a hydrophobic surfactant that has a critical micelle concentration less than 3.0 mM |
| 01/24/2002 | US20020009798 Ob protein compositions and methods |
| 01/24/2002 | US20020009795 Deparaffinizing the sample, heating the sample in a chaotropic solution comprising a guanidinium compound to a temperature about 50-100 degree C. and time period 5-120 minute and recovring RNA, DNA, protein |
| 01/24/2002 | US20020009794 Isolation of RNA from formalin-fixed paraffin-embedded tissue specimens |
| 01/24/2002 | US20020009792 Nucleotide sequences coding protein; for use in wastewater treatment |
| 01/24/2002 | US20020009790 Process for stabilizing proteins in an acidic environment with a pectin high-ester |
| 01/24/2002 | US20020009781 Methods for recombinant peptide production |
| 01/24/2002 | US20020009776 Fibroblast growth factor receptor-like molecules and uses thereof |
| 01/24/2002 | US20020009774 18036,a novel calpain-like protease and uses thereof |
| 01/24/2002 | US20020009773 Nucleotide sequences coding protein associated with apoptosis; for use in treatment of defects of apoptosis and inflammation |
| 01/24/2002 | US20020009772 Novel human calcium channels and related probes, cell lines and mehtods |
| 01/24/2002 | US20020009771 G protein coupled receptor proteins, their production and use |
| 01/24/2002 | US20020009767 Frozen tissue microarrays and methods for using the same |
| 01/24/2002 | US20020009758 Compositions and methods for the therapy and diagnosis of lung cancer |
| 01/24/2002 | US20020009750 Monoclonal antibodies specific to vegf receptors and uses thereof |
| 01/24/2002 | US20020009746 Device for selectively filtering under reduced pressure and for vacuum drying sample liquids or drops of sample liquids as well as use of said device |
| 01/24/2002 | US20020009743 That proliferate in an in vitro culture, obtained by differentiating primate pluripotent stem (pPS) cells, where certain proportion of cells are committed to form neuronal cells, glial cells, or both; screening compounds |
| 01/24/2002 | US20020009739 Metastatic breast and colon cancer regulated genes |
| 01/24/2002 | US20020009738 Diagnostic methods based on detecting a breast tumor protein, or mRNA encoding such protein, in a sample; oligonucleotide hybridization and/or amplification to simultaneously detect two or more tissue-specific polynucleotides in a sample |
| 01/24/2002 | US20020009737 Kits employing oligonucleotide-binding e-tag probes |